Literature DB >> 1997101

Photodynamic therapy of a mouse glioma: intracranial tumours are resistant while subcutaneous tumours are sensitive.

E A Lindsay1, M C Berenbaum, R Bonnett, D G Thomas.   

Abstract

Subcutaneous and intracranial VMDk tumours were treated with photodynamic therapy (PDT) using a new sensitiser, m-THPP. Subcutaneous tumours were highly sensitive to PDT but intracranial tumours were much more resistant, requiring a 30-fold increase in sensitiser dose to produce equivalent levels of necrosis. Resistance of intracerebral tumours was not due to failure of the sensitiser to enter tumours. Necrosis of intracranial tumours was increased when mice breathed 100% oxygen during PDT while subcutaneous tumour necrosis was unaffected.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997101      PMCID: PMC1971766          DOI: 10.1038/bjc.1991.57

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Astrocytomas in an inbred mouse strain.

Authors:  H Fraser
Journal:  J Pathol       Date:  1971-04       Impact factor: 7.996

2.  Optical properties of human brain.

Authors:  L O Svaasand; R Ellingsen
Journal:  Photochem Photobiol       Date:  1983-09       Impact factor: 3.421

Review 3.  A pharmacologic basis for brain tumor chemotherapy.

Authors:  V A Levin
Journal:  Semin Oncol       Date:  1975-03       Impact factor: 4.929

4.  Photoradiation therapy in the treatment of malignant brain tumors: a phase I (feasibility) study.

Authors:  E R Laws; D A Cortese; J H Kinsey; R T Eagan; R E Anderson
Journal:  Neurosurgery       Date:  1981-12       Impact factor: 4.654

5.  The development of an animal model of glioma for use in experimental neuro-oncology.

Authors:  R Bradford; J L Darling; D G Thomas
Journal:  Br J Neurosurg       Date:  1989       Impact factor: 1.596

6.  Survival in glioblastoma: historical perspective.

Authors:  M Salcman
Journal:  Neurosurgery       Date:  1980-11       Impact factor: 4.654

7.  Development of a protocol for photoradiation therapy of malignant brain tumors: part 1. Photosensitization of normal brain tissue with hematoporphyrin derivative.

Authors:  D E Rounds; S Jacques; C H Shelden; C A Shaller; R S Olson
Journal:  Neurosurgery       Date:  1982-10       Impact factor: 4.654

8.  Fast attempts at the photodynamic treatment of human gliomas.

Authors:  C Perria; T Capuzzo; G Cavagnaro; R Datti; N Francaviglia; C Rivano; V E Tercero
Journal:  J Neurosurg Sci       Date:  1980 Jul-Dec       Impact factor: 2.279

9.  The mechanism of photodynamic inactivation of human cells in vitro in the presence of haematoporphyrin.

Authors:  J Moan; E O Pettersen; T Christensen
Journal:  Br J Cancer       Date:  1979-04       Impact factor: 7.640

10.  In vivo biological activity of the components of haematoporphyrin derivative.

Authors:  M C Berenbaum; R Bonnett; P A Scourides
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

View more
  3 in total

1.  Subcutaneous Xenograft Models for Studying PDT In Vivo.

Authors:  Girgis Obaid; Tayyaba Hasan
Journal:  Methods Mol Biol       Date:  2022

2.  The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy.

Authors:  L Lilge; M C Olivo; S W Schatz; J A MaGuire; M S Patterson; B C Wilson
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

Review 3.  Animal models for photodynamic therapy (PDT).

Authors:  Zenildo Santos Silva; Sandra Kalil Bussadori; Kristianne Porta Santos Fernandes; Ying-Ying Huang; Michael R Hamblin
Journal:  Biosci Rep       Date:  2015-09-28       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.